Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5376
Vanguard Russell 2000 Growth ETF
VTWG
$1.46B
| $3.41M | ﹤0.01% |
+11,843
| New | +$3.15M |
|
5377
Annexon
ANNX
$751M
| $3.41M | ﹤0.01% |
596,582
-3,553
| -0.6% | -$19.6K |
|
5378
CALL
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
$5.64B
| $3.41M | ﹤0.01% |
61,300
+38,500
| +169% | +$2.09M |
|
5379
CALL
Eversource Energy
ES
$25.6B
| $3.4M | ﹤0.01% |
47,100
-580,000
| -92% | -$40.2M |
|
5380
Golub Capital BDC
GBDC
$3.23B
| $3.4M | ﹤0.01% |
264,210
+233,716
| +766% | +$3.05M |
|
5381
CALL
Agios Pharmaceuticals
AGIO
$2B
| $3.4M | ﹤0.01% |
91,700
+26,000
| +40% | +$789K |
|
5382
PUT
Range Resources
RRC
$9.23B
| $3.4M | ﹤0.01% |
91,500
-31,600
| -26% | -$1.28M |
|
5383
CALL
Arteris
AIP
$1.03B
| $3.4M | ﹤0.01% |
70,000
+44,200
| +171% | +$1.41M |
|
|
EMA
5384
CALL
Emera Inc
EMA
$15B
| $3.4M | ﹤0.01% |
+64,100
| New | +$3.36M |
|
|
TRAX
5385
First Tracks Biotherapeutics
TRAX
$1.41B
| $3.4M | ﹤0.01% |
+168,790
| New | +$3.16M |
|
5386
PUT
Bruker
BRKR
$9.28B
| $3.39M | ﹤0.01% |
56,400
+3,500
| +7% | +$163K |
|
5387
PUT
Spire Global
SPIR
$445M
| $3.39M | ﹤0.01% |
182,300
+30,500
| +20% | +$567K |
|
5388
Compass Diversified
CODI
$831M
| $3.39M | ﹤0.01% |
+317,939
| New | +$3.47M |
|
5389
CALL
Commercial Metals
CMC
$7.37B
| $3.39M | ﹤0.01% |
54,000
-12,500
| -19% | -$879K |
|
|
NTSK
5390
PUT
Netskope Inc
NTSK
$7.13B
| $3.39M | ﹤0.01% |
309,500
+73,300
| +31% | +$747K |
|
5391
CALL
Iovance Biotherapeutics
IOVA
$4.48B
| $3.39M | ﹤0.01% |
813,900
+54,900
| +7% | +$209K |
|
5392
GCM Grosvenor
GCMG
$774M
| $3.39M | ﹤0.01% |
+275,248
| New | +$3.01M |
|
5393
Dimensional International Core Equity 2 ETF
DFIC
$15.2B
| $3.39M | ﹤0.01% |
90,860
-230,658
| -72% | -$8.65M |
|
5394
Sutro Biopharma
STRO
$263M
| $3.39M | ﹤0.01% |
101,965
-15,572
| -13% | -$486K |
|
|
LADR
5395
Ladder Capital
LADR
$1.21B
| $3.38M | ﹤0.01% |
339,984
+72,827
| +27% | +$739K |
|
5396
PUT
MarketAxess Holdings
MKTX
$5.75B
| $3.38M | ﹤0.01% |
29,800
+8,800
| +42% | +$1.25M |
|
5397
CALL
Lightpath Technologies
LPTH
$645M
| $3.38M | ﹤0.01% |
206,800
-17,600
| -8% | -$246K |
|
5398
CALL
Patterson-UTI
PTEN
$4.66B
| $3.38M | ﹤0.01% |
368,300
+67,900
| +23% | +$758K |
|
|
JFLX
5399
JPMorgan Flexible Debt ETF
JFLX
$1.53B
| $3.38M | ﹤0.01% |
67,049
+9,303
| +16% | +$466K |
|
5400
CALL
The RealReal
REAL
$1.16B
| $3.38M | ﹤0.01% |
286,600
+28,100
| +11% | +$300K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.